EADV 2016 Conference Review - reviewed by A/Professor Pablo Fernandez Peñas

In this review:

Inflammation in carcinogenesis
Unexpected new drivers in melanoma pathogenesis
The pathophysiology of neutrophilic diseases
The importance of autoinflammation in daily practice
Classical and potential indications for IL-1 antagonists
Is there a role for IL-5 antagonists?
Are targeted therapies appropriate as neoadjuvant treatment?
The dermatological indications for imatinib
Immunotherapies for Merkel cell carcinoma
Combinations with anti-PD1 therapies in advanced melanoma
BRAF and MEK inhibitors
Possibilities and limitations of PD1 antagonists
Anti-CTLA4 and -PD1 combination therapies
Dupilumab in moderate-to-severe atopic dermatitis
Efficacy and safety of guselkumab in psoriasis

Please login below to download this issue (PDF)

Subscribe